# PubMed record PMID 41545261

> PeptideScanner retained PubMed bibliographic metadata for PMID 41545261 at 2026-08-10T10:49:08.747Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-01-16. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41545261-tesamorelin:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-02
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41545261-tesamorelin/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41545261-tesamorelin-v1.json
- Content SHA-256: `0143035877916d78de1bbb8b2e41b841b2e92f8b920bb5bcf3ae924aaf7fff07`

## Claims and source pins

### Headline

PubMed record PMID 41545261 ([`pubmed-observation-pmid-41545261-2026-08-02-2172c39e7e97`](#source-pubmed-observation-pmid-41545261-2026-08-02-2172c39e7e97))

### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41545261 at 2026-08-10T10:49:08.747Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-01-16. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41545261-2026-08-02-2172c39e7e97`](#source-pubmed-observation-pmid-41545261-2026-08-02-2172c39e7e97))

### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41545261 at 2026-08-10T10:49:08.747Z. PubMed recorded a metadata revision date of 2026-08-02 and an Entrez history date of 2026-01-16. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41545261-2026-08-02-2172c39e7e97`](#source-pubmed-observation-pmid-41545261-2026-08-02-2172c39e7e97))

### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41545261-2026-08-02-2172c39e7e97`](#source-pubmed-observation-pmid-41545261-2026-08-02-2172c39e7e97))

## Sources

<a id="source-pubmed-observation-pmid-41545261-2026-08-02-2172c39e7e97"></a>
- **PubMed record PMID 41545261 · retained source version 1:2026-08-02:current:2172c39e7e97ce046da26d60e5a4fed7b73be5f89478292ec4ec34191afd5615** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41545261/) (`pubmed-observation-pmid-41545261-2026-08-02-2172c39e7e97`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "PubMed record PMID 41545261." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41545261-tesamorelin-v1.json SHA-256: 0143035877916d78de1bbb8b2e41b841b2e92f8b920bb5bcf3ae924aaf7fff07.